“Appendix 3B New issue announcement, application for quotation of additional securities and agreement” of 19 June, 2018 is posted.
View and download Appendix 3B New issue announcement, application for quotation of additional securities and agreement of 19 June, 2018.
Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
January 31, 2026
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has